The weaver mutant mouse as a model of nigrostriatal dysfunction

J. R. Simon, Bernardino Ghetti

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The weaver mutant mouse has a genetic defect that results in the loss of dopamine neurons in the nigrostriatal pathway. Striatal tyrosine hydroxylase and dopamine content are reduced by 60-70%, and dopamine uptake is reduced by as much as 95%. Deficits in all three of these striatal dopamine markers are seen as early as postnatal d 3. The striatal dopamine systems in the weaver apparently have the ability to compensate for this dopamine deficit. Thus, in the weaver, in vitro resting release, as well as amphetamine-evoked fractional release of endogenous dopamine are increased. An additional change seen in the weaver striatum is an elevated serotonin content. These alterations may play an adaptive role in attempting to compensate for the dopamine loss. In summary, the weaver mutant mouse has dramatic deficits in the nigrostriatal pathway, but also seems to develop certain adaptive mechanisms in dopaminergic and other transmitter systems that may compensate functionally for the dopamine deficit. Thus, the weaver mouse provides a unique animal model for studying naturally induced neuronal degeneration that complements those models using surgical and pharmacological protocols.

Original languageEnglish
Pages (from-to)183-189
Number of pages7
JournalMolecular Neurobiology
Volume9
Issue number1-3
DOIs
StatePublished - Aug 1994

Fingerprint

Neurologic Mutant Mice
Dopamine
Corpus Striatum
Anatomic Models
Dopaminergic Neurons
Tyrosine 3-Monooxygenase
Amphetamine
Serotonin
Animal Models
Pharmacology

Keywords

  • dopamine
  • mouse
  • neuronal degeneration
  • Striatum
  • weaver

ASJC Scopus subject areas

  • Neuroscience(all)
  • Physiology

Cite this

The weaver mutant mouse as a model of nigrostriatal dysfunction. / Simon, J. R.; Ghetti, Bernardino.

In: Molecular Neurobiology, Vol. 9, No. 1-3, 08.1994, p. 183-189.

Research output: Contribution to journalArticle

@article{b17d79d8cb4d49bea3a98d5e670fe3c3,
title = "The weaver mutant mouse as a model of nigrostriatal dysfunction",
abstract = "The weaver mutant mouse has a genetic defect that results in the loss of dopamine neurons in the nigrostriatal pathway. Striatal tyrosine hydroxylase and dopamine content are reduced by 60-70{\%}, and dopamine uptake is reduced by as much as 95{\%}. Deficits in all three of these striatal dopamine markers are seen as early as postnatal d 3. The striatal dopamine systems in the weaver apparently have the ability to compensate for this dopamine deficit. Thus, in the weaver, in vitro resting release, as well as amphetamine-evoked fractional release of endogenous dopamine are increased. An additional change seen in the weaver striatum is an elevated serotonin content. These alterations may play an adaptive role in attempting to compensate for the dopamine loss. In summary, the weaver mutant mouse has dramatic deficits in the nigrostriatal pathway, but also seems to develop certain adaptive mechanisms in dopaminergic and other transmitter systems that may compensate functionally for the dopamine deficit. Thus, the weaver mouse provides a unique animal model for studying naturally induced neuronal degeneration that complements those models using surgical and pharmacological protocols.",
keywords = "dopamine, mouse, neuronal degeneration, Striatum, weaver",
author = "Simon, {J. R.} and Bernardino Ghetti",
year = "1994",
month = "8",
doi = "10.1007/BF02816118",
language = "English",
volume = "9",
pages = "183--189",
journal = "Molecular Neurobiology",
issn = "0893-7648",
publisher = "Humana Press",
number = "1-3",

}

TY - JOUR

T1 - The weaver mutant mouse as a model of nigrostriatal dysfunction

AU - Simon, J. R.

AU - Ghetti, Bernardino

PY - 1994/8

Y1 - 1994/8

N2 - The weaver mutant mouse has a genetic defect that results in the loss of dopamine neurons in the nigrostriatal pathway. Striatal tyrosine hydroxylase and dopamine content are reduced by 60-70%, and dopamine uptake is reduced by as much as 95%. Deficits in all three of these striatal dopamine markers are seen as early as postnatal d 3. The striatal dopamine systems in the weaver apparently have the ability to compensate for this dopamine deficit. Thus, in the weaver, in vitro resting release, as well as amphetamine-evoked fractional release of endogenous dopamine are increased. An additional change seen in the weaver striatum is an elevated serotonin content. These alterations may play an adaptive role in attempting to compensate for the dopamine loss. In summary, the weaver mutant mouse has dramatic deficits in the nigrostriatal pathway, but also seems to develop certain adaptive mechanisms in dopaminergic and other transmitter systems that may compensate functionally for the dopamine deficit. Thus, the weaver mouse provides a unique animal model for studying naturally induced neuronal degeneration that complements those models using surgical and pharmacological protocols.

AB - The weaver mutant mouse has a genetic defect that results in the loss of dopamine neurons in the nigrostriatal pathway. Striatal tyrosine hydroxylase and dopamine content are reduced by 60-70%, and dopamine uptake is reduced by as much as 95%. Deficits in all three of these striatal dopamine markers are seen as early as postnatal d 3. The striatal dopamine systems in the weaver apparently have the ability to compensate for this dopamine deficit. Thus, in the weaver, in vitro resting release, as well as amphetamine-evoked fractional release of endogenous dopamine are increased. An additional change seen in the weaver striatum is an elevated serotonin content. These alterations may play an adaptive role in attempting to compensate for the dopamine loss. In summary, the weaver mutant mouse has dramatic deficits in the nigrostriatal pathway, but also seems to develop certain adaptive mechanisms in dopaminergic and other transmitter systems that may compensate functionally for the dopamine deficit. Thus, the weaver mouse provides a unique animal model for studying naturally induced neuronal degeneration that complements those models using surgical and pharmacological protocols.

KW - dopamine

KW - mouse

KW - neuronal degeneration

KW - Striatum

KW - weaver

UR - http://www.scopus.com/inward/record.url?scp=0028491609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028491609&partnerID=8YFLogxK

U2 - 10.1007/BF02816118

DO - 10.1007/BF02816118

M3 - Article

C2 - 7888095

AN - SCOPUS:0028491609

VL - 9

SP - 183

EP - 189

JO - Molecular Neurobiology

JF - Molecular Neurobiology

SN - 0893-7648

IS - 1-3

ER -